Costanza Tacoli

About

In 2019, I completed a PhD on the molecular epidemiology of Plasmodium falciparum drug resistance under the supervision of Prof. Frank Mockenhaupt at the Institute of Tropical Medicine and International Health in Berlin, Germany. During the COVID-19 pandemic, I worked at the Oxford University Clinical Research Unit (OUCRU) in Hanoi, focusing on antimicrobial resistance (AMR) in Northern Vietnam.

From 2021 to the end of 2023, I was a joint postdoctoral researcher at the Institut Pasteur du Cambodge (IPC) in Phnom Penh and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. During this time, I contributed to several projects, including the implementation of a serological test-and-treat (PvSeroTAT) strategy for the prevention of Plasmodium vivax malaria and the development of novel long-amplicon next-generation sequencing tools.

At the turn of 2024, I worked as a technical consultant for WHO Cambodia, supporting the implementation of new strategies for P. vivax malaria elimination in the country. I am currently a postdoctoral researcher at the UNESCO Chair in Interdisciplinary Biotechnology at the University of Rome "Tor Vergata," working on the finalization of the Italy-Chad-Cameroon network on climate change and infectious diseases.

Employment

• University of Rome Tor Vergata Post-doctoral researcher
  2024 - Present
• World Health Organization - Cambodia International Consultant
  2023 - 2023
• Institut Pasteur Postdoctoral Researcher
  2021 - 2023
• Oxford University Clinical Research Unit Microbiology/ AMR Consultant
  2020 - 2021

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Validation of serological markers of recent exposure to Plasmodium vivax in Cambodia: a longitudinal cohort and cross-sectional study
  The Lancet Regional Health - Western Pacific 2026 DOI: 10.1016/j.lanwpc.2026.101966
  +Save
• Molecular epidemiology of Plasmodium falciparum and Plasmodium vivax co-infections and PvDBP gene duplication in relation to Duffy genotypes of individuals from Ethiopia
  Malaria Journal 2026 DOI: 10.1186/s12936-026-06002-y
  +Save
• Validation of Serological Markers of Recent Exposure to Plasmodium Vivax in Cambodia
  2026 DOI: 10.2139/ssrn.6148133
  +Save
• Rapid detection of G6PD deficiency SNPs using a novel amplicon-based minion sequencing assay
  Scientific Reports 2025 DOI: 10.1038/s41598-025-31822-4
  +Save
• High prevalence of mixed Plasmodium falciparum and Plasmodium vivax co-infections in Duffy negative individuals in Ethiopia
  2025 DOI: 10.1101/2025.09.16.25335845
  +Save
• Evaluating the technical feasibility of serological testing and treatment for Plasmodium vivax in mobile at-risk of malaria Cambodian populations
  The Lancet Regional Health - Western Pacific 2025 DOI: 10.1016/j.lanwpc.2025.101518
  +Save
• Prevalence and determinants of faecal carriage of carbapenem- and third-generation cephalosporin-resistant Enterobacterales: a cross-sectional household survey in northern Vietnam
  The Lancet Regional Health - Western Pacific 2025 DOI: 10.1016/j.lanwpc.2024.101281
  +Save
• Prevalence and determinants of nasal carriage of penicillin non-susceptible Streptococcus pneumoniae: a cross-sectional household survey in northern Vietnam
  The Lancet Regional Health - Western Pacific 2025 DOI: 10.1016/j.lanwpc.2024.101282
  +Save
• Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia
  Malaria Journal 2024 DOI: 10.1186/s12936-024-04859-5
  +Save
• Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda
  The American Journal of Tropical Medicine and Hygiene 2023 DOI: 10.4269/ajtmh.23-0143
  +Save
• Feasibility, acceptability, and bacterial recovery for community-based sample collection to estimate antibiotic resistance in commensal gut and upper respiratory tract bacteria.
  Scientific reports 2022 DOI: 10.1038/s41598-022-27084-z
  +Save
• Changing Pattern of Plasmodium falciparum pfmdr1 Gene Polymorphisms in Southern Rwanda.
  Antimicrobial agents and chemotherapy 2021 DOI: 10.1128/aac.00901-21
  +Save
• Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda.
  Emerging infectious diseases 2021 DOI: 10.3201/eid2701.203527
  +Save
• Molecular and Functional Aspects of Antimalarial Drug Resistance in Isolates from Africa and Asia
  2019
  +Save
• Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany
  The Pediatric Infectious Disease Journal 2019 DOI: 10.1097/inf.0000000000002417
  +Save
• Characterization of Plasmodium vivax pvmdr1 Polymorphisms in Isolates from Mangaluru, India
  Costanza Tacoli, Prabhanjan P. Gai, Konrad Siegert +11 more
  The American Journal of Tropical Medicine and Hygiene 2019 DOI: 10.4269/ajtmh.19-0224
  +Save
• Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine–Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India
  Jakob Wedam, Costanza Tacoli, Prabhanjan P. Gai +11 more
  The American Journal of Tropical Medicine and Hygiene 2018 DOI: 10.4269/ajtmh.18-0549
  +Save
• Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria
  Parasitology Research 2018 DOI: 10.1007/s00436-018-5754-5
  +Save
• Artemisinin Resistance–Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015
  The American Journal of Tropical Medicine and Hygiene 2016 DOI: 10.4269/ajtmh.16-0483
  +Save